News & Views

A discovery of unique proteins in a patient’s individual tumor cells has allowed researchers at @ChildrensNatl to generate personalized T cells to target and kill tumors. https://www.clinicalomics.com/topics/oncology/brain-cancer/proteins-point-the-way-to-precision-treatments-for-medulloblastoma-in-children/ #oncology #precisionmedicine #braincancer #medulloblastoma

A 24-gene signature has been found that is linked to poor outcomes in advanced ER+ #breastcancer. These findings could be used to guide physicians in more #personalizedtreatment selection. https://www.clinicalomics.com/topics/oncology/metastatic-breast-cancer-treatment-resistance-biomarker-discovered/ #biomarkers #biomarkerdiscovery #oncology #precisionmedicine

New research has identified a metabolic enzyme and pathway in triple-negative #breastcancer (#TNBC) patients that they hope could serve as a #biomarker to select patients for #targetedtherapy. https://www.clinicalomics.com/topics/oncology/breast-cancer/pathway-in-triple-negative-breast-cancer-could-provide-biomarker-for-targeted-therapy/ #oncology #precisionmedicine

A collaboration of researchers discovered a protein #biomarker for #Medulloblastoma to help diagnose the childhood #braincancer and work out which patients are likely to need more intense therapy. https://www.clinicalomics.com/topics/oncology/brain-cancer/personalized-treatment-for-medulloblastoma-aided-by-new-antibody-diagnostic/ #oncology #diagnostics #personalizedtreatment

“We have a way for screening for genes that don’t behave and optimizing those that do.”
#PrecisionMedicine #biomarker #drugdiscovery #responderid

Load More...